Biotech | August 25, 2025
Boehringer and AnGes sign manufacturing agreement for HGF gene therapy product
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
This project shall be implemented through incorporation of a new joint venture company in Zambia
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Macitentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension
Sarepta has also entered into an agreement with Arrowhead to transfer 2,660,989 shares of Arrowhead common stock in satisfaction of $50 million of the company’s previously announced $100 million milestone payment obligation
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The projected business potential is around US$ 1 million in the first year
Subscribe To Our Newsletter & Stay Updated
